← Back to Search

Communication App for Post-Operative Pain Control

N/A

Recruiting

Led By Genevieve Melton-Meaux, PhD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Never previously randomized or exposed to OPY

Surgery at The M Health Fairview Clinics and Surgery Center - Maple Grove (Maple Grove) or M Health Fairview Clinics and Surgery Center - Minneapolis (CSC)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Summary

"This trial will evaluate a digital communication tool called OPY, which aims to help patients manage pain after surgery and avoid opioid addiction. Patients will use OPY through an app called MyChart starting the day

Who is the study for?

This trial is for patients who have had outpatient surgery at M Health Fairview Clinics in Maple Grove or Minneapolis, with a new opioid prescription. They must never have used the OPY app before and should be classified as outpatients or same-day surgery patients.

What is being tested?

The study tests an interactive messaging service called OPY against standard care. OPY aims to improve post-surgery pain management and reduce opioid misuse by providing daily advice and behavioral nudges through MyChart's Epic-Care Companion.

What are the potential side effects?

Since this trial involves a communication app rather than medication, traditional side effects are not expected. However, there may be privacy concerns or potential stress related to using digital tools.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never been part of a trial or taken OPY before.

Select...

My surgery will be at an M Health Fairview center in Maple Grove or Minneapolis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Opiate use at 14 days

Secondary study objectives

Number and cause of patient initiated outreach events

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Interactive messaging serviceExperimental Treatment1 Intervention

Participants will be randomized to one of 3 specific versions of OPY.

Group II: standard carePlacebo Group1 Intervention

Standard care currently consists of education materials with the after visit summary (available in MyChart) around opioid use and precautions and disposal information.

0 / 2Eligibility criteria met